Evidence map›Paper›PMID 41160333›Full record

ArticleMedical oncology (Northwood, London, England)2025

BMP-9 promotes the expression of PD-L1 in osteosarcoma cells through FOXO1.

Wei Zhang, Yongxun Ge, Xiaqing Xu

Abstract read
PubMed Publisher
In one paragraph

Article in Medical oncology (Northwood, London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Wei ZhangDepartment of Pharmacy, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, 450007, Henan, China.
Yongxun GeDepartment of Pharmacy, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, 450007, Henan, China.
Xiaqing XuDepartment of Pharmacy, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, 450007, Henan, China. xuxiaqing@zzu.edu.cn.

Funding

Henan Province Joint Construction Project LHGJ20220868Henan Province Science and Technology Research Project 222102310409Henan Provincial Higher Education Key Research Project Program 22A310029
6 · The paper itself

Abstract

Osteosarcoma is the most common primary malignant bone tumor, and its occurrence and development are closely related to the bone microenvironment. Therefore, it is essential to understand the main factors that promote osteosarcoma progression in the bone microenvironment. Our study focused on the effect of BMP-9 on PD-L1 expression in osteosarcoma cells. The expression of PD-L1 was detected western blot and flow cytometry. Using RNA-seq analysis, we explored the mechanism that regulated PD-L1 mRNA expression. Our findings revealed that BMP-9 promoted PD-L1 protein expression in osteosarcoma cells. Further, BMP-9 induced the transcriptional expression of PD-L1 in osteosarcoma cells. RNA sequencing and TCGA database analysis showed that FOXO1 regulates the transcriptional expression of PD-L1. FOXO1 expression was significantly increased under BMP-9 action. Importantly, BMP-9 cannot increase the transcriptional and protein expression of PD-L1 in osteosarcoma cells when FOXO1 is knocked down. Additionally, the expression of BMP-9 was positively correlated with the expression of PD-L1 in clinical samples of osteosarcoma.

Indexed as

B7-H1 AntigenBone NeoplasmsForkhead Box Protein O1Growth Differentiation Factor 2OsteosarcomaCell Line, TumorGene Expression Regulation, NeoplasticHumansB7-H1 AntigenCD274 protein, humanForkhead Box Protein O1FOXO1 protein, humanGDF2 protein, humanGrowth Differentiation Factor 2BMP-9FOXO1OsteosarcomaPD-L1

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.